Artivion: Q3 Earnings Snapshot
Artivion, Inc. (AORT) reported a Q3 loss of $7.9 million, down from a profit last year. Adjusted EPS was 8 cents. Revenue was $123.8 million. The company expects Q4 revenue between $484M and $492M. Shares have fallen 45% YTD and 46% over 12 months.
How this was made
The 30-second read
Why it matters
The earnings miss and modest revenue outlook suggest short‑term downside, but the company may have hidden catalysts.
Market read
The earnings release provides new data for traders; the loss and guidance likely trigger a sell‑off.
What to watch
Potential cost reductions or upcoming product approvals not disclosed in the release.
Background
Artivion is a Kennesaw, GA‑based medical device maker that previously posted a profit in Q3 of the prior year.
Ticker impact
Artivion reported a Q3 loss of $7.9M and guidance for $484‑$492M revenue, a fresh earnings disclosure.
downward pressure as investors price in the loss and guidance
The company posted a loss after a prior profit year and gave revenue guidance that does not signal strong growth.
Market effects
May pressure other small‑cap medical device stocks if guidance is seen as weak.
Limited to U.S. small‑cap segment.
Low global impact.
Counterpoint
If the guidance reflects a strategic pivot, the stock could rebound on long‑term growth potential.
Key entities
- companyArtivion, Inc.
Medical device manufacturer reporting Q3 results.
